SNN | Smith & Nephew plc | [NYSE]
Index- P/E59.08 EPS (ttm)0.51 Insider Own0.60% Shs Outstand436.39M Perf Week-5.65%
Market Cap13.17B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float219.19M Perf Month-7.05%
Income223.00M PEG12.84 EPS next Q- Inst Own9.80% Short Float / Ratio0.59% / 1.37 Perf Quarter4.08%
Sales5.21B P/S2.53 EPS this Y-57.30% Inst Trans8.83% Short Interest1.30M Perf Half Y14.90%
Book/sh12.05 P/B2.50 EPS next Y- ROA2.10% Target Price36.17 Perf Year-8.13%
Cash/sh0.80 P/C37.64 EPS next 5Y4.60% ROE4.10% 52W Range21.77 - 33.08 Perf YTD11.83%
Dividend1.21 P/FCF- EPS past 5Y-22.50% ROI5.30% 52W High-9.11% Beta0.61
Dividend %4.03% Quick Ratio1.00 Sales past 5Y1.80% Gross Margin70.50% 52W Low38.09% ATR0.47
Employees19012 Current Ratio2.20 Sales Q/Q106.90% Oper. Margin8.60% RSI (14)36.60 Volatility1.29% 1.09%
OptionableYes Debt/Eq0.55 EPS Q/Q-85.60% Profit Margin4.30% Rel Volume0.89 Prev Close29.92
ShortableYes LT Debt/Eq0.52 Earnings- Payout148.60% Avg Volume948.45K Price30.07
Recom2.00 SMA20-5.53% SMA50-0.77% SMA20010.80% Volume848,637 Change0.50%
Date Action Analyst Rating Change Price Target Change
Apr-27-23Downgrade HSBC Securities Buy → Hold
Apr-11-23Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-12-22Initiated Citigroup Buy
Nov-28-22Downgrade UBS Neutral → Sell
Oct-18-22Initiated Morgan Stanley Equal-Weight
Jul-28-22Downgrade Canaccord Genuity Buy → Hold $40 → $32
Mar-16-22Initiated RBC Capital Mkts Outperform $1700
Mar-15-22Initiated RBC Capital Mkts Outperform
Mar-04-22Upgrade Redburn Sell → Neutral
Jun-09-21Upgrade Credit Suisse Neutral → Outperform
May-16-23 08:00AM
May-02-23 08:00AM
Apr-25-23 09:21AM
Apr-24-23 08:00AM
Apr-14-23 09:40AM
07:00PM Loading…
Apr-10-23 07:00PM
Apr-09-23 03:59AM
Mar-29-23 09:40AM
Mar-26-23 03:22AM
Mar-24-23 07:49AM
Mar-23-23 08:00AM
Mar-09-23 07:48AM
Mar-08-23 02:46PM
10:00AM Loading…
Mar-07-23 10:00AM
Mar-06-23 09:40AM
Feb-27-23 10:49PM
Feb-24-23 01:05PM
Feb-23-23 12:00PM
Feb-21-23 09:53AM
Jan-30-23 08:00AM
Jan-24-23 02:34PM
Jan-23-23 09:33AM
Jan-12-23 01:05AM
Jan-04-23 08:00PM
08:12PM Loading…
Jan-03-23 08:12PM
Dec-16-22 09:21AM
Dec-08-22 03:51AM
Nov-24-22 03:24AM
Nov-20-22 03:48PM
Nov-09-22 09:36AM
Nov-08-22 11:00PM
Nov-01-22 08:00AM
Oct-18-22 07:25AM
Oct-17-22 10:29AM
Oct-12-22 02:10PM
Oct-11-22 07:26PM
Sep-26-22 02:01PM
Sep-21-22 08:00AM
Sep-19-22 07:00PM
Sep-14-22 12:24PM
Sep-12-22 04:30AM
Aug-09-22 01:00AM
Aug-05-22 01:27AM
Aug-04-22 08:00AM
Jul-28-22 03:30PM
Jul-13-22 08:00AM
Jul-12-22 03:00AM
Jun-30-22 08:00AM
Jun-27-22 04:38AM
Jun-14-22 03:00AM
Jun-08-22 08:00AM
May-29-22 04:36AM
May-11-22 04:31AM
Apr-30-22 06:29AM
Apr-11-22 04:29PM
Apr-08-22 10:15AM
Apr-07-22 08:30AM
Apr-06-22 10:15AM
Apr-05-22 10:15AM
Apr-04-22 11:50AM
Mar-31-22 01:28PM
Mar-29-22 08:30AM
Mar-28-22 08:30AM
Mar-24-22 11:15AM
Mar-23-22 11:15AM
Mar-22-22 11:15AM
Mar-21-22 11:15AM
Mar-18-22 11:15AM
Mar-17-22 08:01PM
Mar-15-22 08:00AM
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.